Conserved cysteine residues determine substrate specificity in a novel As(III) S-adenosylmethionine methyltransferase from Aspergillus fumigatus

被引:24
作者
Chen, Jian [1 ]
Li, Jiaojiao [1 ]
Jiang, Xuan [2 ]
Rosen, Barry P. [1 ]
机构
[1] Florida Int Univ, Dept Cellular Biol & Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA
[2] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA
关键词
ARSENIC METHYLTRANSFERASE; TRIMETHYLARSINE; IDENTIFICATION; BIOTRANSFORMATION; RESISTANCE; SPECIATION; MECHANISM; TOXICITY; GENE;
D O I
10.1111/mmi.13628
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Methylation of inorganic arsenic is a central process in the organoarsenical biogeochemical cycle. Members of every kingdom have ArsM As(III) S-adenosylmethionine (SAM) methyltransferases that methylates inorganic As(III) into mono- (MAs(III)), di- (DMAs(III)) and tri- (TMAs(III)) methylarsenicals. Every characterized ArsM to date has four conserved cysteine residues. All four cysteines are required for methylation of As(III) to MAs(III), but methylation of MAs(III) to DMAs(III) requires only the two cysteines closest to the C-terminus. Fungi produce volatile and toxic arsines, but the physiological roles of arsenic methylation and the biochemical basis is unknown. Here they demonstrate that most fungal species have ArsM orthologs with only three conserved cysteine residues. The genome of Aspergillus fumigatus has four arsM genes encoding ArsMs with only the second, third and fourth conserved cysteine residues. AfArsM1 methylates MAs(III) but not As(III). Heterologous expression of AfarsM1 in an Escherichia coli conferred resistance to MAs(III) but not As(III). The existence of ArsMs with only three conserved cysteine residues suggest that the ability to methylate MAs(III) may be an evolutionary step toward enzymes capable of methylating As(III), the result of a loss of function mutation in organisms with infrequent exposure to inorganic As(III) or as a resistance mechanism for MAs(III).
引用
收藏
页码:250 / 259
页数:10
相关论文
共 30 条
[1]   Structure of an As(III) S-Adenosylmethionine Methyltransferase: insights into the Mechanism of Arsenic Biotransformation [J].
Ajees, A. Abdul ;
Marapakala, Kavitha ;
Packianathan, Charles ;
Sankaran, Banumathi ;
Rosen, Barry P. .
BIOCHEMISTRY, 2012, 51 (27) :5476-5485
[2]   Arsenic speciation and toxicity in biological systems [J].
Akter, KF ;
Owens, G ;
Davey, DE ;
Naidu, R .
REVIEWS OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, VOL 184, 2005, 184 :97-149
[3]   The microbial genomics of arsenic [J].
Andres, Jeremy ;
Bertin, Philippe N. .
FEMS MICROBIOLOGY REVIEWS, 2016, 40 (02) :299-322
[4]   Microbial methylation of metalloids: Arsenic, antimony, and bismuth [J].
Bentley, R ;
Chasteen, TG .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2002, 66 (02) :250-+
[5]   THE ARS OPERON OF ESCHERICHIA-COLI CONFERS ARSENICAL AND ANTIMONIAL RESISTANCE [J].
CARLIN, A ;
SHI, WP ;
DEY, S ;
ROSEN, BP .
JOURNAL OF BACTERIOLOGY, 1995, 177 (04) :981-986
[6]  
Cullen WR, 2005, J ENVIRON MONITOR, V7, P11
[7]   Functional coexistence of twin arsenic resistance systems in Pseudomonas putida KT2440 [J].
David Paez-Espino, A. ;
Durante-Rodriguez, Gonzalo ;
de Lorenzo, Victor .
ENVIRONMENTAL MICROBIOLOGY, 2015, 17 (01) :229-238
[8]   Pathway of Human AS3MT Arsenic Methylation [J].
Dheeman, Dharmendra S. ;
Packianathan, Charles ;
Pillai, Jitesh K. ;
Rosen, Barry P. .
CHEMICAL RESEARCH IN TOXICOLOGY, 2014, 27 (11) :1979-1989
[9]   Environmental exposure to arsenic, AS3MT polymorphism and prevalence of diabetes in Mexico [J].
Drobna, Zuzana ;
Del Razo, Luz M. ;
Garcia-Vargas, Gonzalo G. ;
Sanchez-Pena, Luz C. ;
Barrera-Hernandez, Angel ;
Styblo, Miroslav ;
Loomis, Dana .
JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY, 2013, 23 (02) :151-155
[10]   Identification of an S-adenosylmethionine (SAM) dependent arsenic methyltransferase in Danio rerio [J].
Hamdi, Mohamad ;
Yoshinaga, Masafumi ;
Packianathan, Charles ;
Qin, Jie ;
Hallauer, Janell ;
McDermott, Joseph R. ;
Yang, Hung-Chi ;
Tsai, Kan-Jen ;
Liu, Zijuan .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 262 (02) :185-193